Trial record 5 of 33 for:    " December 09, 2009":" January 08, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Medications for Chronic HIV: Education and Collaboration (MedCHEC)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by Boston University.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
VA Boston Healthcare System
VA Greater Los Angeles Healthcare System
San Diego State University
Tufts University
Information provided by (Responsible Party):
Allen L. Gifford, Boston University
ClinicalTrials.gov Identifier:
NCT01038076
First received: December 19, 2009
Last updated: February 28, 2012
Last verified: February 2012
  Purpose

This study will examine whether a computerized, self-administered assessment of patient medication adherence and health behaviors, plus support for adherence, improves the ability of clinicians to identify adherence problems and leads to better adherence.


Condition Intervention
HIV Infections
Acquired Immunodeficiency Syndrome
Medication Adherence
Behavioral: MedCHEC tablet computer and Adherence Care

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Implementing Computerized Clinical Assessment of HIV Patient Adherence

Resource links provided by NLM:


Further study details as provided by Boston University:

Primary Outcome Measures:
  • Patient adherence to HIV medications, as measured by MEMS data, and by self-report questionnaires. [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 348
Study Start Date: December 2009
Estimated Study Completion Date: June 2012
Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: MedCHEC tablet computer & adherence care
Patients assigned to the intervention answer questions about their medication, medication-taking behavior and risks for non-adherence on the MedCHEC tablet touch-screen computer, which generates provider and patient reports. Patients may be referred to an Adherence Care Manager on the basis of the reports. In addition, patients will receive standard information about adherence.
Behavioral: MedCHEC tablet computer and Adherence Care
Patients answer questions about their medication, medication-taking behavior and risks for non-adherence on the MedCHEC tablet touch-screen computer, which generates patient and provider reports. Patients may be referred to an Adherence Care Manager on the basis of the reports.
Other Names:
  • HIV/Adhere
  • aCASI
No Intervention: Adherence Information Only
Patients assigned to the active comparator arm will receive standard information about adherence.

Detailed Description:

Antiretroviral medications are highly effective in controlling HIV, if patients adhere to the regimen. However, HIV medication adherence problems are very common, and evidence is clear that providers have great difficulty 'diagnosing' poor adherence accurately. If healthcare providers can identify patients with adherence problems, they can intervene to help patients overcome these problems and take their medications as prescribed, which can improve symptoms and quality and length of life. Both clinicians and HIV positive patients will be recruited to this study. Before each clinic visit, patients randomized to the intervention will be asked to answer questions about their medications, medication-taking behavior, and risk-factors for non-adherence on MedCHEC, a tablet touch-screen computer that generates provider and patient reports. We will give these reports to the provider and patient to assist with the clinical visit. Based on the MedCHEC-generated report, the patient may be referred to an Adherence Care Manager (ACM). The ACM will assist the patient in overcoming adherence barriers by telephone and in-clinic counseling. The study will evaluate the effects of this system on adherence and clinical care using both quantitative methods (randomized controlled trials of effects on adherence and providers' adherence estimates), and qualitative methods.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Over 18 years of age
  • Confirmed HIV-positive
  • On or newly starting antiretroviral medication for HIV
  • Under treatment at one of the study sites
  • Available by telephone

Exclusion Criteria:

  • Clinically diagnosed by provider with significant cognitive impairment, or Mini-Mental Status Exam score less than or equal to 22
  • Inability to read English
  • Inability or refusal to use MedCHEC touch-screen computer
  • Inability or refusal to use any form of electronic drug monitoring device (MEMS)
  • Never available by telephone
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01038076

Locations
United States, California
VA Greater Los Angeles Not yet recruiting
Los Angeles, California, United States, 90073
Contact: Gina Akopyan    310-478-3711 ext 49514    gina.akopyan@va.gov   
Principal Investigator: Matthew Goetz, M.D.         
United States, Massachusetts
Boston Medical Center Recruiting
Boston, Massachusetts, United States, 02118
Contact: Vicki Crowningsheild    617-638-7909    vicki.crowningsheild@bmc.org   
Principal Investigator: Paul Skolnik, M.D.         
Sub-Investigator: Helene Hardy, PharmD         
VA Boston Not yet recruiting
Boston, Massachusetts, United States, 02030
Contact: Linda McCoy    781-687-3417    linda.mccoy@va.gov   
Principal Investigator: Allen L Gifford, M.D.         
Sponsors and Collaborators
Boston University
VA Boston Healthcare System
VA Greater Los Angeles Healthcare System
San Diego State University
Tufts University
Investigators
Principal Investigator: Allen L Gifford, M.D. Boston University School of Public Health and School of Medicine
  More Information

No publications provided

Responsible Party: Allen L. Gifford, Professor of Public Health and Medicine, Boston University
ClinicalTrials.gov Identifier: NCT01038076     History of Changes
Other Study ID Numbers: MedCHEC, R01MH076911-02
Study First Received: December 19, 2009
Last Updated: February 28, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Boston University:
HIV
AIDS
adherence
antiretroviral
aCASI
HAART
Complementary Therapies
Adherence Care Manager

Additional relevant MeSH terms:
Acquired Immunodeficiency Syndrome
HIV Infections
Immunologic Deficiency Syndromes
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Slow Virus Diseases
Immune System Diseases

ClinicalTrials.gov processed this record on July 23, 2014